Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.
CONCLUSION: These findings support the hypothesis that carcinogenic pathways for type 1 and type 2 ovarian cancer are different and distinct. The marked reduction in all ovarian cancer risk noted with a history of ectopic pregnancy and salpingectomy implies that the fallopian tube plays a key role in carcinogenesis for both type 1 and type 2 ovarian cancer.
PMID: 27029746 [PubMed - in process]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Adenocarcinoma | Borderline Endometrioid Tumor | Borderline Mucinous Tumor | Borderline Serous Tumor | Borderline Tumor | Cancer | Cancer & Oncology | Carcinosarcoma | Colorectal Cancer | Endometrial Cancer | Fallopian Tube Cancer | Granulosa Cell Tumor | History of Medicine | Hormones | Ibuprofen | Mucinous Ovarian Cancer | OBGYN | Oral Cancer | Ovarian Cancer | Ovaries | Pregnancy | Tubal Ligation | Undifferentiated Carcinoma